Imbed Biosciences Introduces Innovative Wound Care Solution

Revolutionizing Wound Care with Targeted Solutions
Imbed Biosciences Inc. has taken a significant step forward in the field of wound care technology with the launch of its latest product, SAM™ PainGuard™ with Lidocaine. This innovative solution aims to address critical challenges faced in acute wound management by combining pain relief with effective bioburden management in a single, user-friendly matrix. The introduction of this product is poised to improve the experience for both patients and healthcare providers alike, promoting better outcomes in various clinical settings.
Introducing a Dual-Action Wound Matrix
The SAM™ PainGuard™ integrates advanced antimicrobial properties with the analgesic effects of lidocaine. This pioneering addition is tailored for surgical wounds through its ‘Surgaflex™ PainGuard™’ variant, and for burns and traumatic injuries via the ‘Pelashield™ PainGuard™’ variant. Both products highlight Imbed’s commitment to enhancing the wound healing process by allowing for simultaneous infection control and pain management.
Addressing Pain in Post-Surgical Patients
Managing post-surgical pain can be a daunting task. Statistics indicate that nearly 90% of patients struggle with moderate to severe pain post-surgery. Terry Bromley, the CEO of Imbed Biosciences, emphasizes the importance of addressing pain immediately to minimize the reliance on opioid medication. Chronic pain following surgeries can lead to long-term complications such as anxiety disorders and delayed healing. Understanding these challenges, Imbed has designed SAM™ PainGuard™ to incorporate lidocaine effectively, alleviating discomfort and minimizing reliance on traditional pain relief methods.
Immediate and Effective Pain Relief
Clinicians have praised the PainGuard™ matrix for its efficiency, which accommodates a controlled release of lidocaine HCl, delivering nearly 80% of the medication within the first 30 minutes. This rapid absorption allows patients to experience significant pain relief soon after application, making it ideal for a variety of wound types, including surgical, burn, donor sites, and trauma wounds. It can also be particularly beneficial during procedures such as dressing changes and debridement.
Strong Endorsements from Healthcare Professionals
Pre-launch evaluations have showcased strong support from medical professionals testing PainGuard™. Notable testimonials highlight the substantial impact this product has had on patient experiences. For example, one podiatrist noted a patient who ceased using hydrocodone on the first day post-surgery, rating her pain at just 1/10, a stark contrast to typical post-operative pain expectations.
Another general surgeon remarked on the ease of application of the PainGuard™ matrix, underscoring how simple it is to use while ensuring effective pain management for their patients. Such feedback illustrates the potential of this dual-action matrix to transform traditional pain management approaches within clinical practices.
Product Highlights and Features
The SAM™ PainGuard™ brings several remarkable features that bolster its appeal to healthcare providers:
- It combines antimicrobial silver and lidocaine HCl in a dual-action, ultra-thin matrix.
- The porous, bioresorbable polymer is designed to adapt to the micro-textures of wounds without the need for removal.
- Being fully synthetic, it eliminates infection risks associated with animal-derived products.
- The low levels of ionic and metallic silver ensure 72 hours of effective microbial reduction.
- Offers acute pain relief for up to 3 hours after application.
- It has received FDA clearance, confirming its safety and efficacy.
- The product comes in a ready-to-use, unit-dose format, ensuring consistent application.
About Imbed Biosciences Inc.
Imbed Biosciences is at the forefront of wound care innovation, dedicating itself to pioneering technology that enhances patient outcomes. The company’s SAM™ Antimicrobial Technology serves as a unique platform that integrates diverse therapeutic elements into biocompatible matrices aimed at accelerating healing processes while effectively managing infectious threats in a range of wound types.
For additional details, you can explore their website or connect through their various social media platforms, providing vital updates on their products and offerings. Imbed is committed to advancing the wound care landscape and making a significant difference in patient care.
Frequently Asked Questions
What is SAM™ PainGuard™ used for?
SAM™ PainGuard™ is designed to provide pain relief and antimicrobial protection for various wounds, including surgical, burn, and trauma-related injuries.
How long does the pain relief last from SAM™ PainGuard™?
The product provides effective pain relief for up to 3 hours after application.
Who can benefit from using PainGuard™?
Patients undergoing surgeries, experiencing burns, or dealing with traumatic wounds can benefit from the dual-action effects of PainGuard™.
Is SAM™ PainGuard™ FDA approved?
Yes, SAM™ PainGuard™ has received FDA clearance, confirming its safety and efficacy for use.
What are the main ingredients in SAM™ PainGuard™?
The main ingredients include lidocaine HCl for pain relief and antimicrobial silver for infection control, all within a biocompatible matrix.
About The Author
Contact Riley Hayes privately here. Or send an email with ATTN: Riley Hayes as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.